Recent advances in dextran-based drug delivery systems: From fabrication strategies to applications
As a natural polysaccharide, dextran and its derivatives have gained great attention in the
development of delivery systems for pharmaceutical and medical applications. In recent …
development of delivery systems for pharmaceutical and medical applications. In recent …
[HTML][HTML] Superparamagnetic iron oxide nanoparticles—Current and prospective medical applications
The recent, fast development of nanotechnology is reflected in the medical sciences.
Superparamagnetic Iron Oxide Nanoparticles (SPIONs) are an excellent example. Thanks to …
Superparamagnetic Iron Oxide Nanoparticles (SPIONs) are an excellent example. Thanks to …
[HTML][HTML] Magnetite nanoparticles for cancer diagnosis, treatment, and treatment monitoring: recent advances
The development of nanoparticles (NPs) for use in all facets of oncological disease
detection and therapy has shown great progress over the past two decades. NPs have been …
detection and therapy has shown great progress over the past two decades. NPs have been …
Charge‐reversible nanoparticles: advanced delivery systems for therapy and diagnosis
F Veider, E Sanchez Armengol, A Bernkop‐Schnürch - Small, 2024 - Wiley Online Library
The past two decades have witnessed a rapid progress in the development of surface
charge‐reversible nanoparticles (NPs) for drug delivery and diagnosis. These NPs are able …
charge‐reversible nanoparticles (NPs) for drug delivery and diagnosis. These NPs are able …
In Vitro/In Vivo Toxicity Evaluation and Quantification of Iron Oxide Nanoparticles
Increasing biomedical applications of iron oxide nanoparticles (IONPs) in academic and
commercial settings have alarmed the scientific community about the safety and assessment …
commercial settings have alarmed the scientific community about the safety and assessment …
Design considerations for the synthesis of polymer coated iron oxide nanoparticles for stem cell labelling and tracking using MRI
M Barrow, A Taylor, P Murray, MJ Rosseinsky… - Chemical Society …, 2015 - pubs.rsc.org
Iron oxide nanoparticles (IONPs, sometimes called superparamagnetic iron oxide
nanoparticles or SPIONs) have already shown promising results for in vivo cell tracking …
nanoparticles or SPIONs) have already shown promising results for in vivo cell tracking …
Small Scale, Big Impact: Nanotechnology-Enhanced Drug Delivery for Brain Diseases
K Miao, X **a, Y Zou, B Shi - Molecular Pharmaceutics, 2024 - ACS Publications
Central nervous system (CNS) diseases, ranging from brain cancers to neurodegenerative
disorders like dementia and acute conditions such as strokes, have been heavily burdening …
disorders like dementia and acute conditions such as strokes, have been heavily burdening …
Mechanism of surface charge triggered intestinal epithelial tight junction opening upon chitosan nanoparticles for insulin oral delivery
J Wang, M Kong, Z Zhou, D Yan, X Yu, X Cheng… - Carbohydrate …, 2017 - Elsevier
Intestinal epithelium is a major barrier limiting the absorption of oral insulin owing to the
presence of intercellular tight junctions (TJs). Previous studies proved that carboxymethyl …
presence of intercellular tight junctions (TJs). Previous studies proved that carboxymethyl …
[HTML][HTML] Imaging constructs: The rise of iron oxide nanoparticles
BEB Crețu, G Dodi, A Shavandi, I Gardikiotis… - Molecules, 2021 - mdpi.com
Over the last decade, an important challenge in nanomedicine imaging has been the work to
design multifunctional agents that can be detected by single and/or multimodal techniques …
design multifunctional agents that can be detected by single and/or multimodal techniques …
Non-invasive imaging reveals conditions that impact distribution and persistence of cells after in vivo administration
L Scarfe, A Taylor, J Sharkey, R Harwood… - Stem cell research & …, 2018 - Springer
Background Cell-based regenerative medicine therapies are now frequently tested in
clinical trials. In many conditions, cell therapies are administered systemically, but there is …
clinical trials. In many conditions, cell therapies are administered systemically, but there is …